Chargement en cours...
NEDD8 inhibition overcomes CKS1B-induced drug resistance by upregulation of p21 in multiple myeloma
PURPOSE: CKS1B is significantly upregulated in multiple myeloma (MM) and associated with poor prognosis. The identification of novel therapies is essential for effective treatment of patients resistant to chemotherapy. The NEDD8 inhibitor MLN4924 selectively targets SCF(Skp2) activation and offers a...
Enregistré dans:
| Publié dans: | Clin Cancer Res |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4804624/ https://ncbi.nlm.nih.gov/pubmed/26156395 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0254 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|